Holly LaDuca

4.9k citations
64 papers · 2.1k indexed · 1 hit paper · h-index 24
  • Genetics top 1%
    • BRCA gene mutations in cancer 39
    • Genomics and Rare Diseases 16
    • Genomic variations and chromosomal abnormalities 8
    • Nutrition, Genetics, and Disease 7
    • Cancer Genomics and Diagnostics 21
    • Genetic factors in colorectal cancer 26
  • Oncology top 5%
    • Cancer-related Molecular Pathways 3
    • DNA Repair Mechanisms 4

Holly LaDuca

59 papers receiving 2.1k citations

Hit Papers

Associations Between Cancer Predisposition Testing Panel ...3932017202620202023100200300

Peers

Holly LaDuca
Comparison fields: 5 of 102
  • Genetics 1.3k
  • Cancer Research 691
  • Pathology and Forensic Medicine 687
  • Oncology 491
  • Molecular Biology 779
Replace Edward D. Esplin with:
Edward D. Esplin United States
Carrie Snyder United States
Rebecca Nagy United States
Kathleen W. Rao United States
Rita K. Schmutzler Germany
Pedro Pérez‐Segura Spain
Leigha Senter United States
E. von Schoultz Sweden
Cindy A. Eads United States
Philippe Berthon France
Holly LaDuca relative to Edward D. Esplin United States Edward D. Esplin's profile →
Citations per field
00.5×4.4×
Edward D. Esplin · 1×
Citations per year

Countries citing papers authored by Holly LaDuca

Since Specialization
Citations

This map shows the geographic impact of Holly LaDuca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly LaDuca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly LaDuca more than expected).

Fields of papers citing papers by Holly LaDuca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly LaDuca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly LaDuca. The network helps show where Holly LaDuca may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Holly LaDuca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Holly LaDuca Line = papers co-authored together Holly LaDuca links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20230
2 202314
3 20224
4 202248
5 20211
6 202113
7 202129
8 202038
9 202019
10 202032
11 201975
12 201918
13 201911
14 20183
15 201817
16 201845
17 201779
18 201636
19 2014237
20 201049

About Holly LaDuca

Holly LaDuca is a scholar working on Genetics, Pathology and Forensic Medicine and Cancer Research, having authored 64 papers that have together received 2.1k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (39 papers), Genetic factors in colorectal cancer (26 papers), Cancer Genomics and Diagnostics (21 papers), Genomics and Rare Diseases (16 papers), Genomic variations and chromosomal abnormalities (8 papers), Nutrition, Genetics, and Disease (7 papers), DNA Repair Mechanisms (4 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Genetics (1.3k citations), Cancer Research (691 citations) and Pathology and Forensic Medicine (687 citations). Holly LaDuca has collaborated with scholars based in United States, Australia and Türkiye. Frequent co-authors include Jill S. Dolinsky, Elizabeth Chao, Rachel McFarland, Tina Pesaran, Fergus J. Couch, David E. Goldgar, Shuwei Li, Hermela Shimelis, Chunling Hu and Eric C. Polley. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026